The Board of the Aurobindo Pharma Limited at its meeting held today (i.e., April 6, 2026), has inter-alia, considered and approved subject to such approvals of regulatory and/or statutory authorities as may be required under applicable laws, the buyback of up to 54,23,728 (Fifty four lakhs twenty three thousand seven hundred and twenty eight only) fully paid-up equity shares of the Company, each having a face value of INR 1/- (Indian Rupee one only).